Organization
Nancy Lin
2 clinical trials
Clinical trial
A Phase II Study of Atezolizumab in Combination With Pertuzumab Plus High-dose Trastuzumab for the Treatment of Central Nervous System Metastases in Patients With Her2-positive Breast CancerStatus: Active (not recruiting), Estimated PCD: 2020-05-20
Clinical trial
A Phase 2 Study of Lapatinib in Combination With Trastuzumab in Patients With HER2-Positive, Metastatic Breast CancerStatus: Active (not recruiting), Estimated PCD: 2013-11-30